In Vivo Cell Therapies

搜索文档
Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies
Businesswire· 2025-10-03 13:00
BOSTON--(BUSINESS WIRE)-- #AI--Kernal Bio retains strategic independence, while gaining access to shared resources, operational support and Lilly's global network of experts. ...